Role of p53 mutations in the radiosensitivity status of tumor cells

被引:17
作者
Chiarugi, V [1 ]
Magnelli, L [1 ]
Cinelli, M [1 ]
机构
[1] Univ Florence, Inst Gen Pathol, Mol Biol Lab, I-50134 Florence, Italy
关键词
p53; mutations; radiosensitivity;
D O I
10.1177/030089169808400501
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Wild-type p53 is involved in cellular response to DNA damage including cell cycle control, DNA repair and activation of apoptosis, Accumulation of p53 protein following DNA damage may initiate the apoptotic process, resulting rn cell death. DNA damage induced by radiation is an example of apoptotic stimulus involving p53, Regulation of apoptosis by p53 can occur through transcriptional regulation of pro-apoptotic (e.g. bar) and anti-apoptotic (e.g. bel-2) factors. Although wild-type p53 usually sensitizes cells to radiation therapy, p53 mutations have a variable effect on radiation response. For example p53 mutations in bone or breast tumors have been found to be associated with resistance to chemotherapeutic drugs or ionizing radiation, Mutated p53 has has been reported to increase sensitivity to radiation and drugs in colorectal and bladder tumors, The present brief commentary tries to find an explanation at molecular level of these conflicting results.
引用
收藏
页码:517 / 520
页数:4
相关论文
共 32 条
[1]   ACCUMULATION OF WILD-TYPE P53 PROTEIN UPON GAMMA-IRRADIATION INDUCES A G(2) ARREST-DEPENDENT IMMUNOGLOBULIN-KAPPA LIGHT-CHAIN GENE-EXPRESSION [J].
ALONIGRINSTEIN, R ;
SCHWARTZ, D ;
ROTTER, V .
EMBO JOURNAL, 1995, 14 (07) :1392-1401
[2]   COMPLETE SEQUENCING OF THE P53 GENE PROVIDES PROGNOSTIC INFORMATION IN BREAST-CANCER PATIENTS, PARTICULARLY IN RELATION TO ADJUVANT SYSTEMIC THERAPY AND RADIOTHERAPY [J].
BERGH, J ;
NORBERG, T ;
SJOGREN, S ;
LINDGREN, A ;
HOLMBERG, L .
NATURE MEDICINE, 1995, 1 (10) :1029-1034
[3]   THYMOCYTE APOPTOSIS INDUCED BY P53-DEPENDENT AND INDEPENDENT PATHWAYS [J].
CLARKE, AR ;
PURDIE, CA ;
HARRISON, DJ ;
MORRIS, RG ;
BIRD, CC ;
HOOPER, ML ;
WYLLIE, AH .
NATURE, 1993, 362 (6423) :849-852
[4]  
Cote RJ, 1997, NATURE, V385, P123, DOI 10.1038/385123b0
[5]  
DELPHIN C, 1994, J BIOL CHEM, V269, P29579
[6]  
DEPPERT W, 1994, SEMIN CANCER BIOL, V5, P187
[7]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[8]  
Gallagher WM, 1997, ONCOGENE, V14, P185
[9]  
Gallardo D, 1996, CANCER RES, V56, P4891
[10]   Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain [J].
Gu, W ;
Roeder, RG .
CELL, 1997, 90 (04) :595-606